Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DewDiligence_on_SI	9/28/2010 2:47:33 PM
	of 3027

Inequitable conduct is alive and well after all—at least with respect to Taxotere: siliconinvestor.com I mention this because a recent blog vis-à-vis the Temodar patent said, “…the Court of Appeals has turned extremely hostile to the inequitable conduct doctrine recently, and is considering drastically changing it in another case to be heard later this fall. So, the odds of winning an inequitable conduct claim are getting lower by the day.” Whether inequitable conduct will come into play in the Copaxone case remains to be seen, of course.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next